Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer.

Ripoll, Giselle V; Pifano, Marina; Garona, Juan; Alonso, Daniel F.

Afiliação

Ripoll GV; Laboratory of Molecular Oncology, Department of Science and Technology, National University of Quilmes, Bernal, Argentina.
Pifano M; Scientific Investigator Career of National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina.
Garona J; Laboratory of Molecular Oncology, Department of Science and Technology, National University of Quilmes, Bernal, Argentina.
Alonso DF; Laboratory of Molecular Oncology, Department of Science and Technology, National University of Quilmes, Bernal, Argentina.

Front Oncol ; 9: 1490, 2019.

Article em En | MEDLINE | ID: mdl-31998646